Clinical trials
Genital Neoplasms, Female trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 2 |
| Completed | 2 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alterome Therapeutics, Inc. | 1 |
| Atavistik Bio, Inc | 1 |
| Corcept Therapeutics | 1 |
| GamaMabs Pharma | 1 |
| Hoffmann-La Roche | 1 |
| Marengo Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genital Neoplasms, Female | 6 |
| Endometrial Neoplasms | 4 |
| Neoplasms | 4 |
| Neoplasms by Site | 3 |
| Ovarian Neoplasms | 3 |
| Uterine Cervical Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Prostatic Neoplasms | 2 |
| Triple Negative Breast Neoplasms | 2 |
| Urogenital Neoplasms | 2 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.